LXRX
Lexicon Announces Pricing of $85.0 Million Public Offering and Concurrent Private Placement
Thursday, July 28, 2022 BiopharmaWatch Research 1 min read Key Takeaway: Lexicon Announces Pricing of $85.0 Million Public Offering and Concurrent Private Placement
Price reaction · baseline $3.27 (2022-07-27 close) · hit after-hours · 2 other LXRX headline(s) in the window, move may be shared
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+111%
120-day peak, hindsight
Typical move
11%
average across 13 past catalysts
Cash runway
~61 mo
Minimal dilution risk
Lead asset
Sotagliflozin
Phase 3 · Type 1 Diabetes Mellitus
Full Press Release Details
Lexicon Announces Pricing of $85.0 Million Public Offering and Concurrent Private Placement.